Table 3.
Distribution of hospital complications among patients tested for severe acute respiratory syndrome coronavirus 2
| Hospital Complications | Total N=31,540, n (%) | Patients | Controls | P values | |||||
| Severe Acute Respiratory Syndrome Coronavirus 2 +/Kidney Transplant Recipients, N=32, n (%) | Severe Acute Respiratory Syndrome Coronavirus 2 +/Non-Kidney Transplant Recipients, N=3181, n (%) | Severe Acute Respiratory Syndrome Coronavirus 2 −/Kidney Transplant Recipients, N=224, n (%) | Severe Acute Respiratory Syndrome Coronavirus 2 −/Non-Kidney Transplant Recipients, N=28,103, n (%) | P 1 | P 2 | P 3 | P Interaction | ||
| ICU admission | 6287 (20) | 11 (34) | 766 (24) | 55 (25) | 5455 (19) | 0.18 | 0.24 | 0.03 | 0.37 |
| Ventilation | 1850 (6) | 11 (34) | 437 (14) | 20 (9) | 1382 (5) | <0.001 | <0.001 | <0.001 | 0.05 |
| Vasopressor use | 3799 (12) | 13 (41) | 503 (16) | 37 (17) | 3246 (12) | <0.001 | 0.001 | <0.001 | 0.01 |
| AKI | 2882 (9) | 15 (47) | 458 (15) | 51 (23) | 2358 (10) | <0.001 | 0.004 | <0.001 | 0.07 |
| Inpatient mortality | 1317 (4) | 8 (25) | 498 (16) | 5 (2) | 806 (3) | 0.15 | <0.001 | <0.001 | 0.12 |
P values were obtained using the Kruskal-Wallis test. Values in red represent statistically significant differences. P1 tests the difference between SARS-CoV-2–positive KTR and SARS-CoV-2–positive non-KTR, P2 tests the difference between SARS-CoV-2–positive KTR and SARS-CoV-2–negative KTR, P3 tests the difference between SARS-CoV-2–positive KTR and SARS-CoV-2–negative non-KTR, and PInteraction tests the interaction between SARS-CoV-2 and KTR status (a significant interaction P value can be interpreted as the relationship between SARS-CoV-2 infection and outcome is significantly modified by kidney transplant status). ICU, intensive care unit; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; KTR, kidney transplant recipient.